tsao-t has been researched along with nevirapine in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (80.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Balzarini, J; Camarasa, MJ; De Clercq, E; Pérez-Pérez, MJ; San-Félix, A | 1 |
| Balzarini, J; Camarasa, MJ; De Clercq, E; Emini, EA; Karlsson, A; Sardana, VV | 1 |
| Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ; Tarpley, WG | 1 |
| Balzarini, J; Camarasa, MJ; De Clercq, E; Karlsson, A; Pérez-Pérez, MJ | 1 |
| Campiani, G; Catalanotti, B; Fattorusso, C; Maga, G; Morelli, E; Nacci, V; Novellino, E; Ramunno, A | 1 |
1 review(s) available for tsao-t and nevirapine
| Article | Year |
|---|---|
Non-nucleoside HIV-1 reverse transcriptase (RT) inhibitors: past, present, and future perspectives.
Topics: Acquired Immunodeficiency Syndrome; Alkynes; Anti-HIV Agents; Benzodiazepinones; Benzoxazines; Cyclopropanes; Delavirdine; Drug Design; Drug Evaluation, Preclinical; Drug Resistance, Viral; Drug Therapy, Combination; HIV Reverse Transcriptase; HIV-1; Humans; Molecular Structure; Nevirapine; Nucleosides; Oxazines; Reverse Transcriptase Inhibitors; Spiro Compounds; Thymidine; Uridine | 2002 |
4 other study(ies) available for tsao-t and nevirapine
| Article | Year |
|---|---|
3'-Spiro nucleosides, a new class of specific human immunodeficiency virus type 1 inhibitors: synthesis and antiviral activity of [2'-5'-bis-O-(tert-butyldimethylsilyl)-beta-D-xylo- and -ribofuranose]-3'-spiro-5"-[4"-amino-1",2"-oxathiole 2",2"-dioxide] (
Topics: Antiviral Agents; Cells, Cultured; HIV-1; HIV-2; Humans; Molecular Structure; Pyrimidine Nucleosides; Simian Immunodeficiency Virus; Tumor Cells, Cultured; Virus Replication | 1992 |
Human immunodeficiency virus 1 (HIV-1)-specific reverse transcriptase (RT) inhibitors may suppress the replication of specific drug-resistant (E138K)RT HIV-1 mutants or select for highly resistant (Y181C-->C181I)RT HIV-1 mutants.
Topics: Amino Acid Sequence; Antiviral Agents; Base Sequence; Benzodiazepines; Cell Line; Codon; DNA Primers; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Kinetics; Molecular Sequence Data; Nevirapine; Point Mutation; Polymerase Chain Reaction; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Spiro Compounds; Structure-Activity Relationship; Thymidine; Uridine; Virus Replication | 1994 |
Treatment of human immunodeficiency virus type 1 (HIV-1)-infected cells with combinations of HIV-1-specific inhibitors results in a different resistance pattern than does treatment with single-drug therapy.
Topics: Amino Acid Sequence; Antiviral Agents; Benzodiazepines; Cell Line; Dideoxynucleosides; Drug Interactions; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Mutagenesis; Nevirapine; Piperazines; Pyridines; Pyridones; RNA-Directed DNA Polymerase; Spiro Compounds; Thymidine; Uridine | 1993 |
Knocking-out concentrations of HIV-1-specific inhibitors completely suppress HIV-1 infection and prevent the emergence of drug-resistant virus.
Topics: Antiviral Agents; Base Sequence; Benzodiazepines; Cells, Cultured; Dose-Response Relationship, Drug; Drug Resistance, Microbial; HIV Reverse Transcriptase; HIV-1; Humans; Imidazoles; Microbial Sensitivity Tests; Molecular Sequence Data; Nevirapine; Piperazines; Pyridines; Pyridones; Reverse Transcriptase Inhibitors; RNA-Directed DNA Polymerase; Sequence Analysis; Spiro Compounds; Thymidine; Thymine; Uridine; Virus Replication | 1993 |